GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Marinomed Biotech MARI.VI · EUR

Health Care · Wiener Börse · 🇦🇹 Austria

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Marinomed Biotech — daily VIE:MARI Delayed
Price to earnings
0.4

About Marinomed Biotech

Its shares trade on Wiener Börse under the ticker MARI.VI. It has been listed since 1 February 2019. In the fiscal year to 31 December 2025, it reported revenue of €7.7m and net income of €15.3m. At that date it held total assets of €6.0m and shareholders' equity of −€9.8m.

Marinomed Biotech AG is a biopharmaceutical company, which engages in the development of therapies based on patent protected technology platforms. The company is headquartered in Korneuburg, Niederoesterreich. The company went IPO on 2019-02-01. The firm develops antiviral and immunological therapies such as nasal sprays using the respiratory disease antiviral technology platform, Marinosolv and the Carragelose platform. With the Marinosolv technology platform, it is possible to improve the effectiveness of poorly soluble active ingredients. This technology has the potential to change some therapies in the field of allergy and autoimmune diseases. The Carragelose platform is already used in six different products against viral infections of the respiratory tract. The firm also offers products for the treatment of influenza, combination products for asthmatics, and others. The firm also develops treatments for type I allergies and autoimmune diseases. The firm is a spin-off from the University of Veterinary Medicine, Vienna.

Figures and description from our data supplier, not checked against the company's own report.

More about Marinomed Biotech →

Latest on Marinomed Biotech

Our reporting

We have not reported on Marinomed Biotech yet.

Next results

21 Apr 2027

Due on 21 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Marinomed Biotech's ticker?

Marinomed Biotech trades as MARI.VI on Wiener Börse, under ISIN ATMARINOMED6.

What was Marinomed Biotech's last closing price?

We have not recorded a close for this listing yet. The chart above carries pricing from TradingView.

When does Marinomed Biotech next report results?

Results are expected on 21 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.